Overview
Race, Ethnicity, and Breast Cancer: Health Equity Panel Discussion
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County.
In this panel discussion and workshop, experts from the University of Chicago Medicine and the University of Illinois Cancer Center discuss structural racism and disparities faced by women receiving breast cancer care. Discussion is centered around strategies to address these disparities. The experts are also joined by patient advocates sharing their personal experience and how providers can provide support.
This activity is intended for clinical (oncologists, surgical oncologists, radiologists, oncology nurses, OB-GYNs, internal medicine physicians, NPs, PAs and technologists) and administrative teams (case managers, patient navigators, assistive personnel) who care for breast cancer patients.
Compared to white women, Black women are less likely to be diagnosed with breast cancer. However, Black women are more likely to be diagnosed at a later stage, have more aggressive subtypes, and experience delays in receiving a diagnosis. Most devastatingly, they are more likely to die from their cancer.
Upon completion of this activity, participants will be able to:
• Outline factors that contribute to cultural competence in health
• List strategies to improve cultural competence and reduce health disparities
• Discuss the roles of healthcare providers, families, and communities in supporting racially diverse women with breast cancer
• Outline factors that contribute to cultural competence in health
• List strategies to improve cultural competence and reduce health disparities
• Discuss the roles of healthcare providers, families, and communities in supporting racially diverse women with breast cancer
Sponsored by the University of Chicago Comprehensive Cancer Center, the University of Chicago Center for Continuing Medical Education, University of Illinois Chicago Cancer Center and their Chicago Cancer Screening and Testing Access Coalition (CCSTAC), and the Academy for Continued Healthcare Learning (ACHL).
Supported by educational grants from Daiichi Sankyo and AstraZeneca.
Candace Henley
Chief Surviving Officer
The Blue Hat Foundation, Inc.
Chief Surviving Officer
The Blue Hat Foundation, Inc.
Joanne Glenn
Founder & C.E.O. WOT Foundation, Inc.
Women on Top of their Game, Inc.
Brenda Battle, MBA, BSN, RN
SVP Community Health Transformation
Chief Equity Officer
University of Chicago Medical Center
Chicago, IL
SVP Community Health Transformation
Chief Equity Officer
University of Chicago Medical Center
Chicago, IL
Monica Peek, MD, MPH
Ellen H. Block Professor of Health Justice
Associate Director, Chicago Center for Diabetes Translational Research
University of Chicago
Chicago, IL
Pamela Ganschow, MD
Director, Cancer Prevention
and Survivorship Clinical Programs
Associate Professor of Clinical Medicine
University of Illinois Cancer Center
Chicago, IL
The University of Chicago Pritzker School of Medicine requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Monica Peek, MD, MPH, (Faculty)
Physician Panel: Pfizer
The following financial relationships have been provided:
Monica Peek, MD, MPH, (Faculty)
Physician Panel: Pfizer
The following individuals have no relevant financial relationships with ineligible companies to disclose:
• Brenda Battle, MBA, BSN, RN
• Pamela Ganschow, MD
• Joanne Glenn
• Candace Henley
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to view the online activity and complete the evaluation. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
